Tower Research Capital LLC (Trc) Imara Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$3.73 - $5.2 $14,300 - $19,936	3,834 New	3,834 $16,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $1.87 $821 - $1,552	-830 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.15 - $2.41 $4,623 - $9,688	-4,020 Reduced 82.89%	830 $2,000
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.05 $6,151 - $11,072	2,734 Added 129.21%	4,850 $11,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $8,608 - $16,521	2,110 Added 35166.67%	2,116 $9,000
Q2 2021 Aug 16, 2021	SELL	$6.78 - $9.04 $12,109 - $16,145	-1,786 Reduced 99.67%	6 $0
Q1 2021 May 17, 2021	SELL	$8.18 - $23.98 $25,153 - $73,738	-3,075 Reduced 63.18%	1,792 $15,000
Q4 2020 Feb 16, 2021	BUY	$15.81 - $29.0 $2,276 - $4,176	144 Added 3.05%	4,867 $107,000
Q3 2020 Nov 16, 2020	BUY	$18.75 - $28.58 $73,537 - $112,090	3,922 Added 489.64%	4,723 $96,000
Q2 2020 Aug 13, 2020	BUY	$15.6 - $54.87 $12,495 - $43,950	801 New	801 $22,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.